News & Events
-
May 13, 2013
Alignment of New Tuberculosis Drug Regimens and Drug Susceptibility Testing: A Framework for Action
Wells WA, Boehme CC, Cobelens FGJ, Daniels C, Dowdy D, Gardiner E, Gheuens J, Kim P, Kimerling ME, Kreiswirth B, Lienhardt C, Mdluli K, Pai M, Perkins MD, Peter T, Zignol M, Zumla A, Schito M. Alignment of New Tuberculosis Drug Regimens and Drug Susceptibility Testing: A Framework for Action. The Lancet Infectious Diseases. 2013 May;13(5):449–58.
-
May 1, 2013
Tuberculosis Comorbidity with Communicable and Non-Communicable Diseases: Integrating Health Services and Control Efforts
Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A. Tuberculosis Comorbidity with Communicable and Non-Communicable Diseases: Integrating Health Services and Control Efforts. The Lancet Infectious Diseases. 2013 May;13(5):436–48.
-
April 1, 2013
Zero Deaths from Tuberculosis: Progress, Reality, and Hope
Zumla A, Kim P, Maeurer M, Schito M. Zero Deaths from Tuberculosis: Progress, Reality, and Hope. The Lancet Infectious Diseases. 2013 Apr;13(4):285–7.
-
April 1, 2013
Tuberculosis Biomarkers Discovery: Developments, Needs, and Challenges
Wallis RS, Kim P, Cole S, Hanna D, Andrade BB, Maeurer M, Schito M, Zumla A. Tuberculosis Biomarkers Discovery: Developments, Needs, and Challenges. The Lancet Infectious Diseases. 2013 Apr;13(4):362–72.
-
March 24, 2013
Advances in Tuberculosis Diagnostics: The Xpert MTB/RIF Assay and Future Prospects for a Point-of-Care Test
Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A. Advances in Tuberculosis Diagnostics: The Xpert MTB/RIF Assay and Future Prospects for a Point-of-Care Test. The Lancet Infectious Diseases. 2013 Mar 24;13(4):349–61.